Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Akhtar

Showing results (381-390 of 404) with videos related to

Pageof 41
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
The British Journal of Psychiatry. Supplement|September 26, 2002
Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomesS Lewis, N Tarrier, G Haddock, et al.
Plos One|May 26, 2017
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaRizwan S Akhtar, Sharon X Xie, Yin J Chen, et al.
Drug Metabolism and Personalized Therapy|April 6, 2022
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Drug Metabolism and Personalized Therapy|July 8, 2021
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Journal of Parkinson'S Disease|January 25, 2021
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) StudyThomas F Tropea, Noor Amari, Noah Han, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Functional & Integrative Genomics|March 27, 2023
Whole-exome sequencing analyses in a Saudi Ischemic Stroke Cohort reveal association signals, and shows polygenic risk scores are related to Modified Rankin Scale RiskFahad A Alkhamis, Majed M Alabdali, Abdulla A Alsulaiman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 23, 2017
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in PakistanA Javaid, R Hasan, A Zafar, et al.
Research Square|October 7, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy BodiesGeorge T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Pageof 41

Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
The British Journal of Psychiatry. Supplement|September 26, 2002
Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomesS Lewis, N Tarrier, G Haddock, et al.
Plos One|May 26, 2017
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaRizwan S Akhtar, Sharon X Xie, Yin J Chen, et al.
Drug Metabolism and Personalized Therapy|April 6, 2022
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Drug Metabolism and Personalized Therapy|July 8, 2021
Prevalence of <i>CYP2C19*2</i> carriers in Saudi ischemic stroke patients and the suitability of using genotyping to guide antiplatelet therapy in a university hospital setupAbdullah M Al-Rubaish, Fahad A Al-Muhanna, Abdullah M Alshehri, et al.
Journal of Parkinson'S Disease|January 25, 2021
Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) StudyThomas F Tropea, Noor Amari, Noah Han, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Functional & Integrative Genomics|March 27, 2023
Whole-exome sequencing analyses in a Saudi Ischemic Stroke Cohort reveal association signals, and shows polygenic risk scores are related to Modified Rankin Scale RiskFahad A Alkhamis, Majed M Alabdali, Abdulla A Alsulaiman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 23, 2017
Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in PakistanA Javaid, R Hasan, A Zafar, et al.
Research Square|October 7, 2024
α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy BodiesGeorge T Kannarkat, Rebecca Zack, R Tyler Skrinak, et al.
Pageof 41